Quality of Life and Depression in Rheumatoid Arthritis Patients Treated with Biologics - A Single Centre Experience

被引:5
作者
Tanski, Wojciech [1 ]
Szalonka, Adrianna [2 ]
Tomasiewicz, Beata [1 ]
机构
[1] 4th Mil Teaching Hosp, Dept Internal Med, Weigla 5, PL-50981 Wroclaw, Poland
[2] 4th Mil Teaching Hosp, Ctr Res & Innovat, Wroclaw, Poland
来源
PSYCHOLOGY RESEARCH AND BEHAVIOR MANAGEMENT | 2022年 / 15卷
关键词
rheumatoid arthritis; quality of life; depression; anxiety; predictors; ATTRIBUTABLE ACTIVITY LIMITATION; DOCTOR-DIAGNOSED ARTHRITIS; DISEASE-ACTIVITY; RA PATIENTS; PREVALENCE; BURDEN; VALIDATION; REMISSION; ADULTS; IMPACT;
D O I
10.2147/PRBM.S352984
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Introduction: Patients with rheumatoid arthritis (RA) often experience depression, which has a very negative impact on the assessment of the quality of life (QoL). However, there are not many studies that assess the relationship between depression and QoL in RA patients. The aim of the study was to assess the level of QoL and determine the mutual relationship between anxiety and depression levels and QoL in patients treated for RA. Material and Methods: The study included 101 patients (aged:52.4 +/- 16.97), who met the established criteria for a diagnosis of RA and treatment with a biological agent. Only standardized tools were used to examine the patients: WHO-QoL, HADS and the VAS scale. Results: The mean RA duration in the group studied was 13.54 +/- 9.51 years and the disease activity score was 4.8 +/- 0.8. The mean QoL perception score was 3.48 +/- 0.8. Nearly 40% of the respondents could not clearly determine their QoL, perceiving it as neither poor nor good, and 10% believed their QoL is poor or very poor. The correlation analysis revealed that anxiety is significantly and negatively associated with QoL in the psychological domain (r = -0.472, p < 0.001) and social domain (r = -0.298, p = 0.023) and depression is significantly and negatively associated with QoL in the psychological domain (r = -0.322, p = 0.01) and physical health domain (r = -0.209, p = 0.04). In the multiple linear regression model, depression was an independent negative predictor affecting the following domains: perception of QoL and perception of health, and physical health. Conclusion: RA patients treated with biologics present a low level of health perception and an average level of QoL perception. Depression and anxiety negatively correlate with QoL domains: the higher the anxiety and depression levels, the poorer the QoL in the psychological and social relationships domains. Depression is an independent determinant of decreased QoL.
引用
收藏
页码:491 / 501
页数:11
相关论文
共 50 条
  • [21] Social support and quality of life in patients with rheumatoid arthritis in Greece
    Pitsilka, D. A.
    Kafetsios, K.
    Niakas, D.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2015, 33 (01) : 27 - 33
  • [22] The frequency and factors affecting anxiety and depression in patients with rheumatoid arthritis
    Enginar, Ayse Unal
    Nur, Hakan
    REUMATOLOGIA, 2023, 61 (01): : 30 - 37
  • [23] Factors associated with anxiety and depression in rheumatoid arthritis patients: a cross-sectional study
    Uda, Miyabi
    Hashimoto, Motomu
    Uozumi, Ryuji
    Torii, Mie
    Fujii, Takao
    Tanaka, Masao
    Furu, Moritoshi
    Ito, Hiromu
    Terao, Chikashi
    Yamamoto, Wataru
    Sugihara, Genichi
    Nakagami, Yukako
    Mimori, Tsuneyo
    Nin, Kazuko
    ADVANCES IN RHEUMATOLOGY, 2021, 61 (01)
  • [24] The association of disease activity with depression and sleep quality in patients with rheumatoid arthritis in Hong Kong
    Chau, Shuk Yi Lucia
    Leung, Moon Ho Alexander
    Tang, Wai Kwong
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2023, 26 (12) : 2543 - 2550
  • [25] Psychological status is associated with health related quality of life in patients with rheumatoid arthritis
    Nas, Kemal
    Sarac, Aysegul Jale
    Gur, Ali
    Cevik, Remzi
    Altay, Zuhal
    Erdal, Akin
    Ersoy, Yuksel
    Kaya, Arzu
    Tekeoglu, Ibrahim
    Ugur, Mahir
    Durmus, Bekir
    Ardicoglu, Ozge
    Senel, Kazim
    Baysal, Ozlem
    Kamanli, Ayhan
    Karatay, Saliha
    Yildirim, Kadir
    Ozgocmen, Salih
    JOURNAL OF BACK AND MUSCULOSKELETAL REHABILITATION, 2011, 24 (02) : 95 - 100
  • [26] Efficacy of Therapeutic Education for Patients With Rheumatoid Arthritis Treated With Biologics
    Bouden, Selma
    Ben Ayed, Hiba
    Khemir, Haifa
    Rouached, Leila
    Ben Tekaya, Aicha
    Mahmoud, Ines
    Tekaya, Raoudha
    Saidane, Olfa
    Abdelmoula, Leila
    MUSCULOSKELETAL CARE, 2025, 23 (01)
  • [27] The impact of psychiatric disorders on quality of life in patients with rheumatoid arthritis
    Uguz, Faruk
    Kucuksarac, Seher
    Akman, Cemal
    Tufekci, Osman
    ANADOLU PSIKIYATRI DERGISI-ANATOLIAN JOURNAL OF PSYCHIATRY, 2009, 10 (02): : 94 - 99
  • [28] ALEXITHYMIA, DEPRESSION, ANXIETY LEVELS AND QUALITY OF LIFE IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Kucuk, A.
    Balkarli, A.
    Kayhan, F.
    Nas, O.
    Ozhan, N.
    Karahan, A. Y.
    Gungor, T.
    Kucuksen, S.
    EUROPEAN PSYCHIATRY, 2014, 29
  • [29] Characterisation of depressive symptoms in rheumatoid arthritis patients treated with tocilizumab during routine daily care
    Behrens, F.
    Burmester, G-R
    Feuchtenberger, M.
    Kellner, H.
    Kuehne, C.
    Liebhaber, A.
    Wassenberg, S.
    Gerlach, J.
    Zortel, M.
    Hofmann, M. W.
    Amberger, C.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2022, 40 (03) : 551 - 559
  • [30] Disease Activity (Rheumatoid Arthritis Disease Activity Index-5) in Patients With Rheumatoid Arthritis and its Association With Quality of Life, Pain, Fatigue, and Functional and Psychological Status
    Sunar, Ismihan
    Garip, Yesim
    Yilmaz, Ozlem
    Bodur, Hatice
    Ataman, Sebnem
    ARCHIVES OF RHEUMATOLOGY, 2015, 30 (02) : 144 - 149